Department of Defense Fiscal Year 2004 Neurofibromatosis Research Program (NFRP) Clinical Trial Development Award (CTDA)

The summary for the Department of Defense Fiscal Year 2004 Neurofibromatosis Research Program (NFRP) Clinical Trial Development Award (CTDA) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

Department of Defense Fiscal Year 2004 Neurofibromatosis Research Program (NFRP) Clinical Trial Development Award (CTDA): Due to the scope and magnitude of the NFRP Clinical Trial Awards, the Clinical Trial Development Award has been instituted to provide support for the development of a multi-institutional NF-related clinical trial, including the establishment of the research team, the development of tools for data management and trial/research administration, the definition of recruitment strategies, and the development of the clinical protocol and other essential components of the study included in a Manual of Operations and Procedures. The goal of these awards is to develop clinical trials with the potential to have a major impact on the treatment of either NF1, NF2, or Schwannomatosis. Participating institutions must be willing to resolve potential intellectual property issues and to remove institutional barriers that might interfere with achieving high levels of cooperation to ensure the successful completion of the clinical trials